Skip to market wire
Back to Market返回行情

ADRX ADARx Pharmaceuticals, Inc.

NASDAQIndustrials
$18.25-6.60%ClosedMarket Cap: $1.87B

As of 2026-10-02

Why ADRX matters now

ADARx Pharmaceuticals, Inc. (ADRX) is a US stock in Industrials. The latest InvestLog snapshot shows $18.25 with -6.60% on the session and $1.87B in market capitalization.

The latest indexable market news headline is "ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares Granted in Its Initial Public Offering" from GlobeNewsWire.

Company Info

Sector

Industrials

Industry

Specialty Business Services

Country

US

Exchange

NASDAQ

Beta

0.00

ADARx Pharmaceuticals, Inc. is a late-clinical-stage biotechnology company. It focuses on developing next-generation small interfering RNA (siRNA) therapeutics for diseases with significant unmet medical needs. The company was founded by Zhen Li in December 2019 and is headquartered in San Diego, CA.